Vaccines and immune checkpoint inhibitors: a promising combination strategy in gastrointestinal cancers.

Babar BashirJohn C FlickingerAdam E Snook

Published in: Immunotherapy (2021)

Tweetable abstract US FDA-approved immune checkpoint inhibitors have limited efficacy for gastrointestinal cancers such as #colorectalcancer and #pancreaticcancer. Could combinations with experimental cancer 'vaccines' be the key?

Keyphrases

papillary thyroid
childhood cancer
squamous cell
drug administration
young adults